1. Home
  2. EDAP vs ICCC Comparison

EDAP vs ICCC Comparison

Compare EDAP & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • ICCC
  • Stock Information
  • Founded
  • EDAP 1979
  • ICCC 1982
  • Country
  • EDAP France
  • ICCC United States
  • Employees
  • EDAP N/A
  • ICCC N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • EDAP Health Care
  • ICCC Health Care
  • Exchange
  • EDAP Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • EDAP 53.8M
  • ICCC 48.3M
  • IPO Year
  • EDAP 1997
  • ICCC 1987
  • Fundamental
  • Price
  • EDAP $2.22
  • ICCC $5.07
  • Analyst Decision
  • EDAP Buy
  • ICCC
  • Analyst Count
  • EDAP 3
  • ICCC 0
  • Target Price
  • EDAP $8.50
  • ICCC N/A
  • AVG Volume (30 Days)
  • EDAP 77.7K
  • ICCC 27.6K
  • Earning Date
  • EDAP 05-15-2025
  • ICCC 05-14-2025
  • Dividend Yield
  • EDAP N/A
  • ICCC N/A
  • EPS Growth
  • EDAP N/A
  • ICCC N/A
  • EPS
  • EDAP N/A
  • ICCC N/A
  • Revenue
  • EDAP $66,378,507.00
  • ICCC $26,493,169.00
  • Revenue This Year
  • EDAP $0.74
  • ICCC N/A
  • Revenue Next Year
  • EDAP $0.37
  • ICCC N/A
  • P/E Ratio
  • EDAP N/A
  • ICCC N/A
  • Revenue Growth
  • EDAP 6.11
  • ICCC 51.63
  • 52 Week Low
  • EDAP $1.26
  • ICCC $3.34
  • 52 Week High
  • EDAP $7.36
  • ICCC $5.82
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 61.30
  • ICCC 42.10
  • Support Level
  • EDAP $2.02
  • ICCC $5.01
  • Resistance Level
  • EDAP $2.25
  • ICCC $5.72
  • Average True Range (ATR)
  • EDAP 0.18
  • ICCC 0.18
  • MACD
  • EDAP 0.06
  • ICCC -0.05
  • Stochastic Oscillator
  • EDAP 86.87
  • ICCC 14.96

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: